tradingkey.logo
搜索

OptimizeRx Corp

OPRX
添加自选
6.050USD
-0.220-3.51%
收盘 07-31 16:00美东报价延迟15分钟
113.53M总市值
16.38市盈率 TTM

关于 OptimizeRx Corp 公司

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corp简介

公司代码OPRX
公司名称OptimizeRx Corp
上市日期May 18, 2005
CEOSilvestro (Stephen L)
员工数量106
证券类型Ordinary Share
年结日May 18
公司地址260 Charles Street
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02453
电话12486516558
网址https://www.optimizerx.com/
公司代码OPRX
上市日期May 18, 2005
CEOSilvestro (Stephen L)

OptimizeRx Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
46.27K
+74.60%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
44.73K
-3.51%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
32.73K
-5.48%
Ms. Lynn O'Connor Vos
Ms. Lynn O'Connor Vos
Independent Chairperson of the Board
Independent Chairperson of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%

常见问题

OptimizeRx Corp的前五大股东是谁?

OptimizeRx Corp 的前五大股东如下:Mr. James (Jim) Lang

有多少机构持有OptimizeRx Corp(OPRX)的股份?

截至2026Q1,共有300家机构持有OptimizeRx Corp的股份,合计持有的股份价值约为15.47M,占公司总股份的82.46%。与2025Q4相比,机构持股有所增加,增幅为-5161941.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有